|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.98 USD | +1.74% |
|
+0.25% | -12.21% |
| 05-01 | UBS Adjusts Price Target on Exponent to $75 From $85, Maintains Neutral Rating | MT |
| 04-30 | Exponent, Inc., Q1 2026 Earnings Call, Apr 30, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 81.67 | +33.92% | 3 | ||||||
| 208.69 | +15.06% | 16 | ||||||
| 127.73 | +13.22% | 11 | ||||||
| 156.93 | +22.71% | 15 | ||||||
| 31.47 | +15.69% | 17 | ||||||
| 58.44 | +0.41% | 13 | ||||||
| 24.07 | +2.77% | 14 | ||||||
| 295.92 | +2.61% | 12 | ||||||
| 74.31 | +15.21% | 8 | ||||||
| - | 272.67 | -0.33% | 3 | |||||
| 42.45 | +45.89% | 11 | ||||||
| 153 | +50.74% | 2 | ||||||
| 41.75 | +54.52% | 8 | ||||||
| 77.77 | +49.84% | 13 | ||||||
| - | 50.27 | +12.78% | 3 | |||||
| 1,364 | +26% | 5 | ||||||
| 3.104 | +34.26% | 12 | ||||||
| 52.43 | +18.43% | 7 | ||||||
| 2.055 | +35.11% | 10 | ||||||
| Average | 164.14 | +23.62% | 10 | ||||||
| Weighted average by Cap. | 162.8 | +17.30% | 13 |
- Stock Market
- Stocks
- EXPO Stock
- Sector Exponent, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
